α-Synuclein impairs macroautophagy: Implications for Parkinson's disease

708Citations
Citations of this article
702Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Parkinson's disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the autophagy defect caused by α-synuclein. Inhibition of autophagy by α-synuclein overexpression or Rab1a knockdown causes mislocalization of the autophagy protein, Atg9, and decreases omegasome formation. Rab1a, α-synuclein, and Atg9 all regulate formation of the omegasome, which marks autophagosome precursors. © 2010 Winslow et al.

Cite

CITATION STYLE

APA

Winslow, A. R., Chen, C. W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., … Rubinsztein, D. C. (2010). α-Synuclein impairs macroautophagy: Implications for Parkinson’s disease. Journal of Cell Biology, 190(6), 1023–1037. https://doi.org/10.1083/jcb.201003122

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free